Sagar Kokare

Sagar Kokare added article Health
2024-05-29 06:37:45 -

Dacarbazine Market Size, Share and Growth Analysis 2034
Dacarbazine, also referred to by its acronym DTIC, is a chemotherapeutic drug that is mostly used to treat certain cancers, such as Hodgkin's lymphoma and metastatic malignant melanoma. It belongs to the triazine family and is categorized as an alkylating agent. It works against cancer by damaging DNA in cancer cells, which prevents them from replicating and repairing themselves, which...

0 Comments 0 Shares

Please log in to like, share and comment!
Sagar Kokare added article Health
2024-05-29 06:34:44 -

Cetuximab Market Size, Share: A Comprehensive Analysis 2034
A drug called cetuximab, marketed under the brand name Erbitux, is used to treat head and neck cancer and metastatic colorectal cancer. It is an intravenous infusion of a chimeric monoclonal antibody (human/mouse). It prevents certain cancer cells from expressing the protein known as the epidermal growth factor receptor (EGFR). EGFR promotes cancer cell division and growth. Cetuximab can aid in...

0 Comments 0 Shares

Please log in to like, share and comment!
Sagar Kokare added article Health
2024-05-23 07:55:39 -

Dacarbazine Market Size, Trends Report, Regional Outlook and Forecast to 2034
Dacarbazine, sometimes referred to as DTIC, is a chemotherapeutic drug used to treat several kinds of cancer. It belongs to the triazine family and is categorized as an alkylating agent. It functions by obstructing the proliferation of cancer cells. The medication accomplishes this by damaging DNA, which prevents these cells from replicating and repairing themselves, ultimately resulting in...

0 Comments 0 Shares

Please log in to like, share and comment!
Sagar Kokare added article Health
2024-05-18 08:22:22 -

Cladribine Market Share, Industry Size, Leading Companies Outlook, Upcoming Challenges and Opportunities till 2034
The synthetic antineoplastic drug cladribine is mainly used to treat specific forms of lymphoma and leukemia. It comes from a class of medications called purine analogs, which disrupt DNA synthesis and repair, eventually causing fast-dividing cells, like cancer cells, to die. Cladribine market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is...

0 Comments 0 Shares

Please log in to like, share and comment!
Sagar Kokare added article Health
2024-05-15 06:08:31 -

Cetuximab Market Expert Analysis on Segmentation, Scope, Regional Outlook, Growth Overview & Forecast to 2034
The report titled “Cetuximab Market” has recently been added by We Market Research to get a stronger and more effective business outlook. It provides an in-depth analysis of the different attributes of the industry, such as trends, policies, and customers operating in different geographies. Research analysts use quantitative as well as qualitative analytical techniques to provide...

0 Comments 0 Shares

Please log in to like, share and comment!
Sagar Kokare updated the profile picture
2024-05-14 10:15:32 -

0 Comments 0 Shares

Please log in to like, share and comment!